Gossamer Bio (GOSS) Return on Capital Employed (2022 - 2025)
Historic Return on Capital Employed for Gossamer Bio (GOSS) over the last 4 years, with Q3 2025 value amounting to 0.99%.
- Gossamer Bio's Return on Capital Employed fell 7500.0% to 0.99% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.99%, marking a year-over-year decrease of 7500.0%. This contributed to the annual value of 0.22% for FY2024, which is 5400.0% up from last year.
- As of Q3 2025, Gossamer Bio's Return on Capital Employed stood at 0.99%, which was down 7500.0% from 0.7% recorded in Q2 2025.
- In the past 5 years, Gossamer Bio's Return on Capital Employed ranged from a high of 0.21% in Q4 2024 and a low of 1.27% during Q2 2023
- Its 4-year average for Return on Capital Employed is 0.67%, with a median of 0.71% in 2024.
- As far as peak fluctuations go, Gossamer Bio's Return on Capital Employed surged by 9800bps in 2024, and later plummeted by -7500bps in 2025.
- Gossamer Bio's Return on Capital Employed (Quarter) stood at 0.88% in 2022, then increased by 25bps to 0.66% in 2023, then soared by 68bps to 0.21% in 2024, then plummeted by -375bps to 0.99% in 2025.
- Its Return on Capital Employed stands at 0.99% for Q3 2025, versus 0.7% for Q2 2025 and 0.22% for Q1 2025.